RedHill Biopharma | RDHL - Operating Expenses

Stock Price
0.87
Daily Change
-0.01 -1.14%
Monthly
-14.71%
Yearly
-66.02%
Q1 Forecast
0.84

RedHill Biopharma reported $5.51M in Operating Expenses for its fiscal quarter ending in June of 2024.





Operating Expenses Change Date
Cara Therapeutics USD 4.96M 2.38M Mar/2025
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 9.78M 90K Sep/2025
Cronos Group USD 51.59M 70.5M Dec/2025
RedHill Biopharma USD 5.51M 1.08M Jun/2024